Next Article in Journal
TGFβ Controls Ovarian Cancer Cell Proliferation
Next Article in Special Issue
The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
Previous Article in Journal
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Previous Article in Special Issue
Chromatin Dynamics in Genome Stability: Roles in Suppressing Endogenous DNA Damage and Facilitating DNA Repair
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(8), 1657;

Polycomb Repressor Complex 2 in Genomic Instability and Cancer

Molecular and Cellular Biology Laboratory, Division of Basic Sciences, University of Crete Medical School, 71003 Heraklion, Greece
Embiodiagnostics Ltd., 71202 Heraklion, Greece
Department of Medical Laboratories, Faculty of Health and Caring Professions, Technological and Educational Institute of Athens, 12243 Athens, Greece
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, 70013 Heraklion, Greece
Author to whom correspondence should be addressed.
Received: 29 June 2017 / Revised: 19 July 2017 / Accepted: 25 July 2017 / Published: 30 July 2017
(This article belongs to the Special Issue Mechanisms Leading to Genomic Instability)
Full-Text   |   PDF [252 KB, uploaded 30 July 2017]   |  


Polycomb repressor complexes PRC1 and PRC2 regulate chromatin compaction and gene expression, and are widely recognized for their fundamental contributions to developmental processes. Herein, we summarize the existing evidence and molecular mechanisms linking PRC-mediated epigenetic aberrations to genomic instability and malignancy, with a particular focus on the role of deregulated PRC2 in tumor suppressor gene expression, the DNA damage response, and the fidelity of DNA replication. We also discuss some of the recent advances in the development of pharmacological and dietary interventions affecting PRC2, which point to promising applications for the prevention and management of human malignancies. View Full-Text
Keywords: polycomb; polycomb repressor complex 2; enhancer of zeste homolog 2; DNA damage response; diet; inhibitors polycomb; polycomb repressor complex 2; enhancer of zeste homolog 2; DNA damage response; diet; inhibitors

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Veneti, Z.; Gkouskou, K.K.; Eliopoulos, A.G. Polycomb Repressor Complex 2 in Genomic Instability and Cancer. Int. J. Mol. Sci. 2017, 18, 1657.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top